RadNet, Inc. reports recurring developments in outpatient diagnostic imaging, digital health, and radiology technology. The company operates owned and managed imaging centers that provide MRI, CT, PET/CT, mammography, ultrasound, X-ray, fluoroscopy, nuclear medicine, and related procedures for physicians and patients across U.S. markets.
RadNet news commonly covers financial results, imaging-center procedure volumes, guidance updates, joint ventures, acquisitions, and customer or technology collaborations. Its Digital Health segment includes DeepHealth, which provides radiology information technology, AI-powered health informatics, clinical AI applications, patient engagement tools, operational AI, teleradiology services, and related products for the diagnostic imaging industry.
RadNet (NASDAQ: RDNT), a national provider of diagnostic imaging services, has scheduled its third quarter 2024 financial results conference call for Monday, November 11, 2024, at 7:30 a.m. Pacific Time (10:30 a.m. Eastern Time). Investors can participate by dialing 844-826-3035 (US) or 412-317-5195 (International). The company will provide simultaneous and archived webcasts of the call, accessible via their website. An archived replay will be available by dialing 844-512-2921 (US) or 412-317-6671 (International) using passcode 10193306.
RadNet, Inc. (NASDAQ: RDNT), a leading provider of diagnostic imaging services, has announced its participation in the Sidoti & Company Small Cap 2024 Virtual Conference. Mark Stolper, Executive Vice President and CFO, will present on Wednesday, September 18th at 4:00 p.m. Eastern Time.
The presentation will be accessible via simultaneous and archived webcasts on the Sidoti platform and RadNet's website. RadNet operates 398 outpatient imaging centers across eight U.S. states and employs over 10,000 people, including affiliated radiologists. The company offers a range of services, including radiology information technology, artificial intelligence solutions, and teleradiology professional services.
RadNet (NASDAQ: RDNT) has appointed Kees Wesdorp as President and CEO of its Digital Health division and a member of the executive management team. Wesdorp, formerly with Philips and Hellman & Friedman, brings extensive experience in radiology software solutions and AI development. He will lead RadNet's digital health products, including eRAD Radiology Information/Image Management Systems and DeepHealth OS, as well as clinical AI solutions in breast, prostate, lung, and neuro imaging.
This appointment signifies RadNet's commitment to strengthening its digital health offerings and accelerating growth in health informatics and AI applications. Wesdorp's expertise is expected to drive innovation in radiology practice, improving efficiency, accuracy, and patient outcomes.
DeepHealth, a RadNet subsidiary, has partnered with HOPPR to advance AI in healthcare. The collaboration aims to commercialize a Medical-Grade Generalized Foundational Model and develop Fine-Tuned models for breast, prostate, and lung cancer detection. This partnership leverages HOPPR's medical-grade infrastructure and DeepHealth's clinical expertise to enhance diagnostic accuracy and workflow efficiency in radiology.
Key points:
- DeepHealth's cloud-native operating system integrates clinical and operational tools
- HOPPR's model enhances medical research and simplifies data collection and training
- The collaboration aims to accelerate AI development in medical imaging
- DeepHealth's technology is used in over 800 clinical sites, performing 15 million exams annually
RadNet, Inc. (NASDAQ: RDNT), a leading provider of outpatient diagnostic imaging services, has announced its participation in the Morgan Stanley 22nd Annual Global Healthcare Conference. Mark Stolper, Executive Vice President and CFO, will present on Thursday, September 5th, 2024, at 11:30 a.m. Eastern Time at the New York Marriott Marquis.
The presentation will be accessible via simultaneous and archived webcasts, providing investors and interested parties an opportunity to gain insights into RadNet's operations and strategy. This event highlights RadNet's commitment to engaging with the investment community and showcasing its position in the healthcare imaging sector.
RadNet (NASDAQ: RDNT) reported strong Q2 2024 financial results, with record quarterly revenue of $459.7 million, up 13.9% year-over-year, and Adjusted EBITDA of $72.3 million, a 19.7% increase. The Digital Health segment saw significant growth, with revenue up 36.4% to $15.8 million, driven by a 136.6% increase in AI revenue. Same-center procedural volumes increased 6.1% compared to Q2 2023. RadNet revised its 2024 guidance upwards, increasing ranges for Revenue, Adjusted EBITDA, and Free Cash Flow. The company completed a successful refinancing, reducing borrowing costs and strengthening its balance sheet with a cash balance of $741.7 million and a Net Debt to Adjusted EBITDA ratio of 1.1.
RadNet, Inc. (NASDAQ: RDNT), a leading provider of high-quality, cost-effective diagnostic imaging services, has announced its upcoming second quarter 2024 financial results conference call. The call is scheduled for Thursday, August 8, 2024, at 7:30 a.m. Pacific Time (10:30 a.m. Eastern Time).
Investors can participate by dialing 844-826-3035 (US) or 412-317-5195 (International). A simultaneous and archived webcast will be available at the provided link. An archived replay can be accessed using the passcode 10191154.
Maryland has enacted new laws to expand access to breast and lung cancer screenings, supported by RadNet. Three bills—HB 1259, HB 0934, and HB 1293—focus on affordability, quality, and education. HB 1259 prohibits copays, coinsurance, and deductibles for certain breast and lung cancer diagnostic imaging, including image-guided breast biopsy and follow-up lung diagnostics. HB 0934 tightens qualifications for x-ray operators, ensuring they meet specific training and continuing education requirements. HB 1293 mandates a three-year public education campaign on cancer prevention, targeting disproportionately affected communities. These laws will take effect in 2025.
RadNet (NASDAQ: RDNT) announced that its Executive Vice President and Chief Financial Officer, Mark Stolper, will present at the Sidoti & Company 2024 Small Cap Conference on June 12th at 12:15 p.m. Eastern Time. The event will be available via simultaneous and archived webcasts.
RadNet is a national leader in providing diagnostic imaging services through a network of outpatient imaging centers.
RadNet (NASDAQ: RDNT) will present at the Goldman Sachs 45th Annual Global Healthcare Conference on June 10, 2024, at 8:40 a.m. ET. Mark Stolper, Executive Vice President and CFO, will represent the company. The conference will be held in Miami, FL, and both live and archived webcasts of the presentation will be accessible via provided URLs and on RadNet's website under 'News and Press Releases'.